Pagano Duilio, Badami Ester, Zito Giovanni, Conaldi Pier Giulio, Vella Ivan, Buscemi Barbara, Amico Giandomenico, Busà Rosalia, Salis Paola, Li Petri Sergio, di Francesco Fabrizio, Calamia Sergio, Bonsignore Pasquale, Tropea Alessandro, Accardo Caterina, Piazza Salvatore, Gruttadauria Salvatore
Abdominal Surgery and Organ Transplant Unit, Department for the Treatment and Study of Abdominal Diseases and Abdominal Transplantation, Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS)-Mediterranean Institute for Transplantation and Advanced Specialized Therapies (ISMETT), University of Pittsburgh Medical Center Italy (UPMCI), 90127 Palermo, Italy.
Department of Laboratory Medicine and Advanced Biotechnologies, Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS)-Mediterranean Institute for Transplantation and Advanced Specialized Therapies (ISMETT), 90127 Palermo, Italy.
J Clin Med. 2023 Jul 20;12(14):4786. doi: 10.3390/jcm12144786.
Ischemia/reperfusion injury (IRI), acute rejection (AR), and delayed graft function (DGF) might occur as major complications following kidney transplantation. Thus, the identification of biomarkers for the IRI, AR, and/or DGF development becomes crucial as it may help to guide post-transplant management. Natural killer (NK) cells, hepatic interstitial T-lymphocytes (T-Li), and NK-T cells are crucial in both innate and adaptive immunity after abdominal solid organ transplantation. Hence, the aim of this study was to evaluate the impact of the immune system after graft reperfusion during KT in adults in order to identify predictive biomarkers.
The NK, T-Li, and NK-T phenotypes and concentrations were retrospectively analyzed in a consecutive series of liver perfusates obtained after organ procurement flushing the abdominal cavity recovered from deceased brain donors (DBDs). Their percentage was compared with the renal transplant recipients' characteristics with kidneys taken from the same DCDs. The hepatic perfusate cells were purified by density gradient centrifugation. Flow cytometric investigation was used to determine their phenotype with the following immunological markers in order to determine the relative percentage of T-Li, NK-T, and NK cells: CD3, CD4, CD8, and CD56.
42 DBDs' liver perfusates were analyzed. The related clinical outcomes of kidney transplant recipients from 2010 to 2020 performed at our Institute were evaluated. Time in days of delayed functional recovery of transplanted kidneys (DGF) ( = 0.02) and the onset of secondary infection from a cytomegalovirus ( = 0.03) were significantly associated with the T-Li percentage. An increased relative risk (HR) of organ survival was significantly associated with the percent cell concentration of T-Li and time to DGF, on COX analysis, were (HR = 1.038, = 0.04; and HR = 1.029, = 0.01, respectively). None relevant clinical outcomes in kidney transplant patients were associated with the specificity of the NK and NK-T cell proportions.
A new potential role of T-Li cells was detected in the context of hepatic perfusate from DBDs. It could detect potential impacts in organ allocation, surgical procuring techniques, and in the analysis of IRI pathophysiological events.
缺血/再灌注损伤(IRI)、急性排斥反应(AR)和移植肾功能延迟恢复(DGF)可能是肾移植后的主要并发症。因此,识别IRI、AR和/或DGF发生的生物标志物至关重要,因为这可能有助于指导移植后管理。自然杀伤(NK)细胞、肝间质T淋巴细胞(T-Li)和NK-T细胞在腹部实体器官移植后的固有免疫和适应性免疫中都起着关键作用。因此,本研究的目的是评估成人肾移植术中移植肾再灌注后免疫系统的影响,以识别预测性生物标志物。
对一系列连续的肝灌注液中的NK、T-Li和NK-T表型及浓度进行回顾性分析,这些肝灌注液是在器官获取后冲洗从脑死亡供体(DBD)获取的腹腔时获得的。将它们的百分比与从相同DCD获取肾脏的肾移植受者的特征进行比较。通过密度梯度离心法纯化肝灌注液细胞。使用流式细胞术研究,用以下免疫标记物确定其表型,以确定T-Li、NK-T和NK细胞的相对百分比:CD3、CD4、CD8和CD56。
分析了42例DBD的肝灌注液。评估了2010年至2020年在本研究所进行的肾移植受者的相关临床结局。移植肾延迟功能恢复(DGF)的天数(=0.02)和巨细胞病毒继发感染的发生(=0.03)与T-Li百分比显著相关。在COX分析中,器官存活的相对风险增加(HR)与T-Li的细胞浓度百分比和至DGF的时间显著相关,分别为(HR = 1.038,= 0.04;HR = 1.029,= 0.01)。肾移植患者中没有相关临床结局与NK和NK-T细胞比例的特异性相关。
在DBD的肝灌注液背景下检测到T-Li细胞的一种新的潜在作用。它可以检测在器官分配、手术获取技术以及IRI病理生理事件分析中的潜在影响。